In recent years, semaglutide has emerged as a breakthrough medication in the treatment of type 2 diabetes, obesity, and even heart health. This injectable medication belongs to the GLP-1 receptor agonists class, which works by mimicking the glucagon-like peptide-1 (GLP-1) hormone that plays a significant role in blood sugar control, https://cristianglrvb.pointblog.net/semaglutide-a-comprehensive-solution-for-obesity-type-2-diabetes-and-heart-health-73169692